PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G
Product details
Registration number: SIN15308P
Classification: Prescription Only
Active ingredients:
- Piperacillin sodium sterile 4.170 g corresponding to Piperacillin
- Tazobactam sodium sterile 536.6 mg corresponding to Tazobactam
Strength:
- 4.0 g
- 0.5g
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: J01CR05
HSA approval date: 31 July 2017
Manufacturer(s):
- Labesfal - Laboratorios Almiro S.A. (Fresenius Kabi Group)
- Fresenius Kabi iPSUM Srl (Villadose plant) (Intermediate)
Manufacturing country/countries: ITALY; PORTUGAL
What are the HSA registration number and classification for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15308P
Classification: Prescription Only
What active ingredients and strength are recorded for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Piperacillin sodium sterile 4.170 g corresponding to Piperacillin
- Tazobactam sodium sterile 536.6 mg corresponding to Tazobactam
Strength:
- 4.0 g
- 0.5g
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Labesfal - Laboratorios Almiro S.A. (Fresenius Kabi Group)
- Fresenius Kabi iPSUM Srl (Villadose plant) (Intermediate)
Manufacturing country/countries: ITALY; PORTUGAL
Where can I look up PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15308P or the exact product name PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G. The general register link does not preselect this product.
What are the source dates for this PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PIPERACILLIN/TAZOBACTAM KABI POWDER FOR SOLUTION FOR INFUSION 4G/0.5G record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15308P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)